Bicycle Therapeutics PLC expected to post a loss of 89 cents a share - Earnings Preview

Bicycle Therapeutics

31/10/2022 11:24

* Bicycle Therapeutics PLC  BCYC.OQ   BCYC.O  is expected
to show
a rise in quarterly revenue when it reports  results on November
2 (estimated). 
    * The Cambridge Cambridgeshire-based  company is expected to
report  a 26.2% increase in revenue to $5.466 million from $4.33
million a year ago, according to the mean estimate from 14
analysts, based on Refinitiv data. 
    * ​Refinitiv's mean analyst estimate for Bicycle
Therapeutics PLC
is for a loss of 89 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 13 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Bicycle
Therapeutics PLC is $57​, above​ its last closing price
of $25.01. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.89       -0.85      -0.90     Missed  -6.1
 Mar. 31 2022  -0.70       -0.68      -0.93     Missed  -36.4
 Dec. 31 2021  -0.67       -0.61      -0.63     Missed  -3.1​
 Sep. 30 2021  -0.63       -0.61      -0.59     Beat    3.5
 ​​Jun.        -0.68       -0.73      -0.74     Missed  -1.9
 30 2021                                                
 Mar. 31 2021  -0.73       -0.71      -0.73     Missed  -3.3​
 Dec. 31 2020  -0.54       -0.47      -0.83     Missed  -75.7
 Sep. 30 2020  -0.51       -0.52      -0.52     Met     -0.5
 This summary was machine generated October 31 at 11:24 GMT.  All
figures in US dollars  unless otherwise stated